PNEUMOCOCCAL INFECTION IN CHILDREN: EVERYDAY PRACTICE

PNEUMOCOCCAL INFECTION IN CHILDREN: EVERYDAY PRACTICE

The detailed analysis of official guidelines aiming optimization of diagnostics and treatment of home-acquired pneumonia (HAP) in children shows, that a number of diagnostic and therapeutic approaches to this condition are not always evidence-based. Everyday clinical practice demonstrates, that diag...

Full description

Bibliographic Details
Main Authors:	L. S. Namazova-Baranova, T. V. Kulichenko, A. E. Malakhova, E. V. Starovoitova, M. D. Bakradze, I. L. Chashchina, I. L. Mitushin
Format:	Article
Language:	English
Published:	"Paediatrician" Publishers LLC 2012-07-01
Series:	Вопросы современной педиатрии
Subjects:	home-acquired pneumonia children diagnostics differential diagnosis severe bacterial infection, treatment, pneumococcal infections, vaccination
Online Access:	https://vsp.spr-journal.ru/jour/article/view/456

Similar Items

The Results of a Three-Year Pneumococcal Vaccination of Children in Russia
by: Nikolay I. Briko, et al.
Published: (2018-10-01)

MODERN POSSIBILITIES AND EFFECTIVENESS OF VACCINE PREVENTION OF PNEUMOCOCCAL INFECTION IN CHILDREN
by: A. L. Zaplatnikov, et al.
Published: (2016-12-01)

Nasopharyngeal Pneumococcal Density and Evolution of Acute Respiratory Illnesses in Young Children, Peru, 2009–2011
by: Roger R. Fan, et al.
Published: (2016-11-01)

Efficacy of conjugate vaccines in pneumococcal infection prevention
by: A. L. Perova, et al.
Published: (2014-09-01)

Vaccinal Prevention of Pneumococcal Infection in Children
by: A. A. Baranov, et al.
Published: (2015-12-01)

Decrease of Pneumococcal Community-Acquired Pneumonia Hospitalization and Associated Complications in Children after the Implementation of the 13-Valent Pneumococcal Conjugate Vaccine (PCV13) in Taiwan
by: Ching-Fen Shen, et al.
Published: (2021-09-01)

Pneumococcal Meningitis in Adults: Clinical-Epidemiological and Diagnostic Aspects
by: T. A. Elistratova, et al.
Published: (2018-06-01)

13-VALENT PNEUMOCOCCAL CONJUGATE VACCINE
by: V. K. Tatochenko, et al.
Published: (2012-03-01)

Comparison of prognostic factors between bacteraemic and non-bacteraemic critically ill immunocompetent patients in community-acquired severe pneumococcal pneumonia: a STREPTOGENE sub-study
by: Hugo Bellut, et al.
Published: (2021-10-01)

The effectiveness of immunization of children against Pneumococcal infection in Penza, Russia
by: O. N. Lesina, et al.
Published: (2019-04-01)

Burden of Hospitalizations Related to Pneumococcal Infection in Spain (2016–2020)
by: Ruth Gil-Prieto, et al.
Published: (2023-01-01)

Hospital burden of pneumococcal disease in Spain (2016–2022): A retrospective study
by: Ruth Gil-Prieto, et al.
Published: (2025-12-01)

CLINICAL AND EPIDEMIOLOGICAL ASSESSMENT OF THE EFFECTIVENESS OF VACCINATION OF CHILDREN AGAINST PNEUMOCOCCAL INFECTION IN THE AMUR REGION
by: A. G. Chuchalin, et al.
Published: (2016-06-01)

The remaining challenges of pneumococcal disease in adults
by: E. Ludwig, et al.
Published: (2012-03-01)

The potential role of pneumococcal conjugate vaccine in reducing acute respiratory inflammation in community-acquired pneumococcal pneumonia
by: Ching-Fen Shen, et al.
Published: (2020-08-01)

Community acquired paediatric pneumonia; experience from a pneumococcal vaccine- naive population
by: Sanath Thushara Kudagammana, et al.
Published: (2020-08-01)

Risk of community acquired pneumonia in patients with diabetes mellitus: Review
by: Galina L. Ignatova, et al.
Published: (2022-03-01)

Vaccinal Prevention of Lower Respiratory Tract Pneumococcal Disease in Adults Without Immunosuppression
by: I. A. Guchev
Published: (2020-05-01)

23-Valent Pneumococcal Polysaccharide Vaccination Does Not Prevent Community-Acquired Pneumonia Hospitalizations Due to Vaccine-Type <i>Streptococcus pneumoniae</i>
by: Thomas Chandler, et al.
Published: (2022-03-01)

VACCINATION AGAINST PNEUMOCOCCAL INFECTIONS IN RUSSIAN FEDERATION: SOCIAL AND PHARMACOECONOMIC ASPECTS
by: A. V. Rudakova, et al.
Published: (2018-10-01)

Meeting the challenge: prevention of pneumococcal disease with conjugate vaccines
by: Echániz-Avilés Irma Gabriela, et al.
Published: (2001-01-01)

PECULIARITIES OF THE PNEUMOCOCCAL PNEUMONIAE IN CHILDREN
by: T. A. Daminov, et al.
Published: (2015-08-01)

COMMUNITY-ACQUIRED PNEUMONIA PNEUMOCOCCAL ETIOLOGY AND MICROBIOLOGICAL ASPECTS OF NASOPHARYNGEAL CARRIAGE IN CHILDREN IN THE REPUBLIC OF TATARSTAN
by: L. T. Bayazitova, et al.
Published: (2017-09-01)

Etiology of Clinical Community-Acquired Pneumonia in Swedish Children Aged 1–59 Months with High Pneumococcal Vaccine Coverage—The TREND Study
by: Annika Eklundh, et al.
Published: (2021-04-01)

Pneumococcal Serotypes Associated with Community-Acquired Pneumonia Hospitalizations in Adults in Spain, 2016–2020: The CAPA Study
by: Rosario Menéndez, et al.
Published: (2023-11-01)

Vaccine Prevention of Pneumococcal Infection in Children
by: Alexander A. Baranov, et al.
Published: (2018-07-01)

Host genetic variants associated with susceptibility and severity of pneumococcal pneumonia in adult patients
by: Lucía Boix-Palop, et al.
Published: (2023-12-01)

Increased Invasive Pneumococcal Disease, North East England, UK
by: Catherine Houseman, et al.
Published: (2017-01-01)

Clinical and Immunological Aspects of Pneumococcal Vaccination in Patients with Multiple Myeloma
by: I. O. Stoma
Published: (2021-01-01)

A model for predicting bacteremia in patients with community-acquired pneumococcal pneumonia: a retrospective observational study
by: Yasuyoshi Washio, et al.
Published: (2018-01-01)

EFFICIENCY OF PNEUMOCOCCAL VACCINE IN CHILDREN WITH DIFFERENT PATTERNS OF TUBERCULOSIS INFECTION
by: I. F. Dovgalyuk, et al.
Published: (2017-01-01)

Economic Burden of Pneumococcal Disease in Individuals Aged 15 Years and Older in the Liguria Region of Italy
by: Matteo Astengo, et al.
Published: (2021-11-01)

Radiographically confirmed community-acquired pneumonia in hospitalized adults due to pneumococcal vaccine serotypes in Sweden, 2016–2018—The ECAPS study
by: Karin Hansen, et al.
Published: (2023-02-01)

Pneumococcal otogenic meningitis complicated by pneumocephalus, seizures, right-sided hemiplegia and cortical venous thrombosis
by: Jordan Mah, et al.
Published: (2022-01-01)

Estimation of 13-valent Pneumococcal Conjugate Vaccine Efficiency in Infants within National Immunization Schedule
by: Nikolay I. Briko, et al.
Published: (2019-09-01)

Emergence of Streptococcus pneumoniae serotype 19A (Spn19A) in the pediatric population in Bogotá, Colombia as the main cause of invasive pneumococcal disease after the introduction of PCV10
by: Germán Camacho Moreno, et al.
Published: (2020-09-01)

PROPHYLACTIC EFFICACY OF VACCINATION AGAINST PNEUMOCOCCAL INFECTION IN CHILDREN WITH CHRONIC ADENOTONSILLAR DISEASES
by: S. N. Beniova, et al.
Published: (2015-08-01)

Modern Approaches to Vaccinal Prevention of a Pneumococcal Infection in Adults Patients with Diabetes Mellitus (Literature Review)
by: J. A. Paramonova, et al.
Published: (2018-04-01)

Analysis of pneumococcal serotypes distribution to determine a model composition for a Russian pneumococcal conjugate vaccine
by: V. P. Trukhin, et al.
Published: (2022-07-01)

Cost-effectiveness of the 13-valent pneumococcal conjugate vaccine in adults in Portugal versus “no vaccination” and versus vaccination with the 23-valent pneumococcal polysaccharide vaccine
by: Miguel Gouveia, et al.
Published: (2019-04-01)